Jul. 30, 2021

7/30/2021 COVID19 MEETING SUMMARY WITH WHO GENEVA TEAM

In Africa, deaths have increased by 80% over the same period. Much of this increase is being driven by the highly-transmissible Delta variant, which has now been detected in at least 132 countries.
WHO is supporting countries with supplies of oxygen, with guidance to help countries better detect variants, and we continue to work daily with our global networks of experts to understand why the Delta variant spreads so readily.
Today we have taken another step forward, with a letter of intent that sets out the terms of collaboration signed by the partners in the hub: WHO; the Medicines Patent Pool; Afrigen Biologics; the Biologicals and Vaccines Institute of Southern Africa; the South African Medical Research Council and the Africa Centres for Disease Control and Prevention.
WHO’s goal remains to support every country to vaccinate at least 10% of its population by the end of September, at least 40% by the end of this year, and 70% by the middle of next year. Less than 2% of all doses administered globally have been in Africa. Just 1.5% of the continent’s population are fully vaccinated.
In response to the Delta surge, today the Access to COVID-19 Tools Accelerator is launching the Rapid ACT-Accelerator Delta Response, or RADAR, issuing an urgent call for 7.7 billion U.S. dollars for tests, treatments and vaccines.
In parallel, we will need additional financing this year for COVAX to exercise its options to purchase vaccines for 2022.